Omrix Biopharmaceuticals Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	53
ISBN Number	not applicable
Product Code	DAT09415

Price

£265.00
approximately: $521 | €337

PRINT £265 ($521 | €337)

Order above formats by FAX

Summary

Introduction

Omrix Biopharmaceuticals's main focus is to discover, develop and commercialize innovative biosurgical and passive immunotherapy products, utilizing its proprietary protein purification technology and manufacturing know-how. The company has two product lines: biosurgical products, that include products that are used for the control of bleeding and passive immunotherapy products.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Omrix Biopharmaceuticals manufactures and develops products in two areas: biosurgery and passive immunotherapy. The company's marketed biosurgical products include Evicel, Quixil and Evithrom. Passive immunotherapy products include IVIG, VIG and HBIG.

Omrix Biopharmaceuticals's biggest contributor to sales growth out to 2010 will be the sales of Biosurgical products. Revenues from Biosurgical products are expected to increase from $13 million in 2006 to $122 million in 2010, representing an absolute growth of +$109 million during the period.

Omrix aims to make its biosurgical products and passive immunotherapy products the treatments of choice in their respective therapeutic areas. The company also aims to have strategic collaborations partnerships that allow the company to diversify its development risk and develop multiple products which will be a key to its success in these areas.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Discovery and Product Development
- Manufacturing
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Omrix Biopharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Omrix Biopharmaceuticals - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Omrix Biopharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Omrix Biopharmaceuticals - Key Facts
- Table 2: Omrix Biopharmaceuticals - Other Locations and Subsidiaries
- Table 3: Omrix Biopharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Omrix Biopharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Omrix Biopharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Omrix Biopharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: Omrix Biopharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Omrix Biopharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Omrix Biopharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 10: Omrix Biopharmaceuticals - Geographic Breakdown, 2002-2006 ($ Mn)
- Table 11: Omrix Biopharmaceuticals - Marketed Products
- Table 12: Omrix Biopharmaceuticals - in-house Pipeline Products
- Table 13: Omrix Biopharmaceuticals - Collaboration Pipeline Products
- Table 14: Omrix Biopharmaceuticals - Historical Product Sales, 2002-2006 ($ Mn)
- Table 15: Omrix Biopharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 16: Omrix Biopharmaceuticals - Top Competitors
- Table 17: Omrix Biopharmaceuticals - Key Shareholders
- Table 18: Omrix Biopharmaceuticals - SWOT Analysis Summary
- Table 19: Omrix Biopharmaceuticals - Value Chain Analysis
- Table 20: Omrix Biopharmaceuticals - Scorecard
- Table 21: Omrix Biopharmaceuticals - Key Employees
- Table 22: Omrix Biopharmaceuticals - Financial and Operational Overview